Kindred Biosciences (KIN) – FDA
-
Kindred Biosciences (KIN) Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by Parvovirus
-
Kindred Biosciences (KIN) Announces Acceptance of Parvovirus Antibody Prophylaxis Study Data and Approval of Efficacy Indication
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to KIN Stock Lookup